[C:1]([C:4]1[CH:5]=[C:6](/[CH:9]=[C:10]2\[C:11](=[O:27])[NH:12][C:13]3[C:18]\2=[C:17]([C:19]#[C:20][C@@H:21]2[CH2:25][CH2:24][CH2:23][NH:22]2)[C:16]([F:26])=[CH:15][CH:14]=3)[NH:7][CH:8]=1)(=[O:3])[CH3:2].[ClH:28]>O1CCOCC1>[ClH:28].[C:1]([C:4]1[CH:5]=[C:6](/[CH:9]=[C:10]2\[C:11](=[O:27])[NH:12][C:13]3[C:18]\2=[C:17]([C:19]#[C:20][C@@H:21]2[CH2:25][CH2:24][CH2:23][NH:22]2)[C:16]([F:26])=[CH:15][CH:14]=3)[NH:7][CH:8]=1)(=[O:3])[CH3:2]A solution of (S)-(Z)-3-[(4-acetyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-5-fluoro-4-[(pyrrolidin-2-yl)ethynyl]-2H-indol-2-one (25 mg, 0.07 mmol) (Example 109 above) in dioxane (3 mL) was treated with aqueous HCl under vigorous stirring. (S)-(Z)-3-[(4-Acetyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-5-fluoro-4-[(pyrrolidin-2-yl)ethynyl]-2H-indol-2-one hydrochloride salt was obtained upon lyophilization of this solution. (Yield 24 mg, 76%).